Logo image of THEP.PA

THERMADOR GROUPE (THEP.PA) Stock Fundamental Analysis

EPA:THEP - Euronext Paris - Matif - FR0013333432 - Common Stock - Currency: EUR

70  0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to THEP. THEP was compared to 16 industry peers in the Trading Companies & Distributors industry. THEP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. THEP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

THEP had positive earnings in the past year.
THEP had a positive operating cash flow in the past year.
THEP had positive earnings in each of the past 5 years.
Each year in the past 5 years THEP had a positive operating cash flow.
THEP.PA Yearly Net Income VS EBIT VS OCF VS FCFTHEP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 11.17%, THEP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
THEP's Return On Equity of 16.25% is amongst the best of the industry. THEP outperforms 93.75% of its industry peers.
THEP's Return On Invested Capital of 14.70% is amongst the best of the industry. THEP outperforms 93.75% of its industry peers.
THEP had an Average Return On Invested Capital over the past 3 years of 16.08%. This is significantly above the industry average of 8.61%.
Industry RankSector Rank
ROA 11.17%
ROE 16.25%
ROIC 14.7%
ROA(3y)11.63%
ROA(5y)10.7%
ROE(3y)17.91%
ROE(5y)16.69%
ROIC(3y)16.08%
ROIC(5y)15.11%
THEP.PA Yearly ROA, ROE, ROICTHEP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

The Profit Margin of THEP (10.04%) is better than 100.00% of its industry peers.
THEP's Profit Margin has been stable in the last couple of years.
THEP's Operating Margin of 13.92% is amongst the best of the industry. THEP outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of THEP has remained more or less at the same level.
The Gross Margin of THEP (27.73%) is better than 87.50% of its industry peers.
THEP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.92%
PM (TTM) 10.04%
GM 27.73%
OM growth 3Y2.3%
OM growth 5Y-0.34%
PM growth 3Y3.13%
PM growth 5Y1.39%
GM growth 3Y0%
GM growth 5Y0.07%
THEP.PA Yearly Profit, Operating, Gross MarginsTHEP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), THEP is creating value.
THEP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for THEP has been increased compared to 5 years ago.
The debt/assets ratio for THEP has been reduced compared to a year ago.
THEP.PA Yearly Shares OutstandingTHEP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
THEP.PA Yearly Total Debt VS Total AssetsTHEP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

THEP has an Altman-Z score of 5.36. This indicates that THEP is financially healthy and has little risk of bankruptcy at the moment.
THEP has a Altman-Z score of 5.36. This is amongst the best in the industry. THEP outperforms 87.50% of its industry peers.
THEP has a debt to FCF ratio of 0.96. This is a very positive value and a sign of high solvency as it would only need 0.96 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.96, THEP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
THEP has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
THEP has a better Debt to Equity ratio (0.10) than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.96
Altman-Z 5.36
ROIC/WACC2
WACC7.36%
THEP.PA Yearly LT Debt VS Equity VS FCFTHEP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

THEP has a Current Ratio of 2.82. This indicates that THEP is financially healthy and has no problem in meeting its short term obligations.
THEP's Current ratio of 2.82 is amongst the best of the industry. THEP outperforms 87.50% of its industry peers.
A Quick Ratio of 1.22 indicates that THEP should not have too much problems paying its short term obligations.
THEP has a Quick ratio of 1.22. This is in the better half of the industry: THEP outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 1.22
THEP.PA Yearly Current Assets VS Current LiabilitesTHEP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2

3. Growth

3.1 Past

THEP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.67%.
The Earnings Per Share has been growing by 14.66% on average over the past years. This is quite good.
The Revenue for THEP has decreased by -10.37% in the past year. This is quite bad
THEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.30% yearly.
EPS 1Y (TTM)-25.67%
EPS 3Y17.23%
EPS 5Y14.66%
EPS Q2Q%-30.45%
Revenue 1Y (TTM)-10.37%
Revenue growth 3Y13.67%
Revenue growth 5Y13.3%
Sales Q2Q%-16.11%

3.2 Future

The Earnings Per Share is expected to decrease by -1.13% on average over the next years.
The Revenue is expected to decrease by -2.92% on average over the next years.
EPS Next Y-20.63%
EPS Next 2Y-6.97%
EPS Next 3Y-1.13%
EPS Next 5YN/A
Revenue Next Year-13.37%
Revenue Next 2Y-6.51%
Revenue Next 3Y-2.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
THEP.PA Yearly Revenue VS EstimatesTHEP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
THEP.PA Yearly EPS VS EstimatesTHEP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

THEP is valuated correctly with a Price/Earnings ratio of 14.17.
75.00% of the companies in the same industry are more expensive than THEP, based on the Price/Earnings ratio.
THEP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.47.
The Price/Forward Earnings ratio is 12.56, which indicates a correct valuation of THEP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of THEP indicates a somewhat cheap valuation: THEP is cheaper than 62.50% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of THEP to the average of the S&P500 Index (92.74), we can say THEP is valued rather cheaply.
Industry RankSector Rank
PE 14.17
Fwd PE 12.56
THEP.PA Price Earnings VS Forward Price EarningsTHEP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than THEP, based on the Enterprise Value to EBITDA ratio.
62.50% of the companies in the same industry are more expensive than THEP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.18
EV/EBITDA 7.11
THEP.PA Per share dataTHEP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

THEP has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.97
EPS Next 2Y-6.97%
EPS Next 3Y-1.13%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.90%, THEP has a reasonable but not impressive dividend return.
THEP's Dividend Yield is a higher than the industry average which is at 2.77.
THEP's Dividend Yield is a higher than the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 2.9%

5.2 History

The dividend of THEP has a limited annual growth rate of 4.11%.
Dividend Growth(5Y)4.11%
Div Incr Years4
Div Non Decr Years5
THEP.PA Yearly Dividends per shareTHEP.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

32.82% of the earnings are spent on dividend by THEP. This is a low number and sustainable payout ratio.
DP32.82%
EPS Next 2Y-6.97%
EPS Next 3Y-1.13%
THEP.PA Yearly Income VS Free CF VS DividendTHEP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M
THEP.PA Dividend Payout.THEP.PA Dividend Payout, showing the Payout Ratio.THEP.PA Dividend Payout.PayoutRetained Earnings

THERMADOR GROUPE

EPA:THEP (2/5/2025, 9:05:08 AM)

70

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)10-15 2024-10-15
Earnings (Next)02-21 2025-02-21/amc
Inst Owners39.48%
Inst Owner ChangeN/A
Ins Owners11.23%
Ins Owner ChangeN/A
Market Cap644.00M
Analysts82.22
Price Target85.51 (22.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.9%
Yearly Dividend2.08
Dividend Growth(5Y)4.11%
DP32.82%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.27%
PT rev (3m)-5.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.4%
EPS NY rev (3m)-7.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.01%
Revenue NY rev (3m)-5.58%
Valuation
Industry RankSector Rank
PE 14.17
Fwd PE 12.56
P/S 1.11
P/FCF 13.18
P/OCF 11.39
P/B 1.8
P/tB 2.48
EV/EBITDA 7.11
EPS(TTM)4.94
EY7.06%
EPS(NY)5.57
Fwd EY7.96%
FCF(TTM)5.31
FCFY7.59%
OCF(TTM)6.14
OCFY8.78%
SpS63.15
BVpS39
TBVpS28.21
PEG (NY)N/A
PEG (5Y)0.97
Profitability
Industry RankSector Rank
ROA 11.17%
ROE 16.25%
ROCE 20.1%
ROIC 14.7%
ROICexc 16.1%
ROICexgc 21.98%
OM 13.92%
PM (TTM) 10.04%
GM 27.73%
FCFM 8.41%
ROA(3y)11.63%
ROA(5y)10.7%
ROE(3y)17.91%
ROE(5y)16.69%
ROIC(3y)16.08%
ROIC(5y)15.11%
ROICexc(3y)17.37%
ROICexc(5y)16.74%
ROICexgc(3y)23.53%
ROICexgc(5y)22.78%
ROCE(3y)21.96%
ROCE(5y)20.58%
ROICexcg growth 3Y-0.12%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y0.26%
ROICexc growth 5Y1.98%
OM growth 3Y2.3%
OM growth 5Y-0.34%
PM growth 3Y3.13%
PM growth 5Y1.39%
GM growth 3Y0%
GM growth 5Y0.07%
F-Score6
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.96
Debt/EBITDA 0.41
Cap/Depr 70.27%
Cap/Sales 1.32%
Interest Coverage 250
Cash Conversion 61.61%
Profit Quality 83.82%
Current Ratio 2.82
Quick Ratio 1.22
Altman-Z 5.36
F-Score6
WACC7.36%
ROIC/WACC2
Cap/Depr(3y)121.04%
Cap/Depr(5y)135.25%
Cap/Sales(3y)1.94%
Cap/Sales(5y)2.17%
Profit Quality(3y)46.2%
Profit Quality(5y)64.92%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.67%
EPS 3Y17.23%
EPS 5Y14.66%
EPS Q2Q%-30.45%
EPS Next Y-20.63%
EPS Next 2Y-6.97%
EPS Next 3Y-1.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.37%
Revenue growth 3Y13.67%
Revenue growth 5Y13.3%
Sales Q2Q%-16.11%
Revenue Next Year-13.37%
Revenue Next 2Y-6.51%
Revenue Next 3Y-2.92%
Revenue Next 5YN/A
EBIT growth 1Y1.57%
EBIT growth 3Y16.29%
EBIT growth 5Y12.91%
EBIT Next Year-4.77%
EBIT Next 3Y3.15%
EBIT Next 5YN/A
FCF growth 1Y245.7%
FCF growth 3Y19.51%
FCF growth 5YN/A
OCF growth 1Y124.53%
OCF growth 3Y12.93%
OCF growth 5YN/A